8th International Congress on Cancer Metastasis

The 8th iteration of the Congress brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine. With advancements in cancer care and patient-centered treatment planning, cancer survivors today live longer and enjoy a vastly improved quality of life than thought imaginable.

The program follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment and survival. With more detailed understanding of the genomic and molecular characteristics of cancer, we are closer towards the practice of precision medicine with tailored approaches to individual patient or groups of patients. It is our plan to address these issues in detail with the goal to bring basic scientists, oncologists, surgeons and radiologists from around the world together to allow cross-fertilization of ideas resulting in the translation of basic science into clinical application and challenging basic scientists with clinical issues. We hope that with advancements in cancer biology, treatment and care, cancer survivors may live longer and enjoy an improved quality of life than before.